Hanson Wade is a leading organization in scientific research, focused on facilitating the development of safe and effective drugs across various R&D sectors. With a commitment to enhancing personalized medicine, they provide invaluable insights and connections to support targeted therapies for specific patient populations.

One of their key events, the Antifibrotic Drug Development Summit, will take place from November 19-21, 2024, at the Hilton Boston Back Bay. This prestigious summit brings together experts and stakeholders in the field of antifibrotic drug development, spanning two days of informative sessions and networking opportunities. Attendees can take advantage of a dedicated room block at the conference venue, with accommodation options available at a discounted rate.

Hanson Wade also offers additional products, including specialized conferences and intelligence services like Beacon Searchlight, aimed at empowering researchers and developers in their quest for innovative treatments. Join Hanson Wade as they lead the charge in transforming drug development for improved patient care.